Zobrazeno 1 - 10
of 53
pro vyhledávání: '"Rosenstock, J"'
Autor:
Bajaj HS; Endocrine and Metabolic Research, LMC Healthcare, Brampton, Canada., Ásbjörnsdóttir B; Novo Nordisk A/S, Søborg, Denmark., Bari TJ; Novo Nordisk A/S, Søborg, Denmark., Begtrup K; Novo Nordisk A/S, Søborg, Denmark., Vilsbøll T; Clinical Research, Steno Diabetes Center Copenhagen, University of Copenhagen, Herlev, Denmark.; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark., Rosenstock J; Velocity Clinical Research at Medical City, Dallas, Texas, USA.
Publikováno v:
Diabetes, obesity & metabolism [Diabetes Obes Metab] 2024 Sep; Vol. 26 (9), pp. 3810-3820. Date of Electronic Publication: 2024 Jul 01.
Autor:
Rosenstock J; Velocity Clinical Research at Medical City, Dallas, Texas., Frías JP; Velocity Clinical Research, Los Angeles, California., Rodbard HW; Endocrine and Metabolic Consultants, Rockville, Maryland., Tofé S; Department of Endocrinology and Nutrition, University Hospital Son Espases, Palma de Mallorca, Spain., Sears E; Eli Lilly and Company, Indianapolis, Indiana., Huh R; Eli Lilly and Company, Indianapolis, Indiana., Fernández Landó L; Eli Lilly and Company, Indianapolis, Indiana., Patel H; Eli Lilly and Company, Indianapolis, Indiana.
Publikováno v:
JAMA [JAMA] 2023 Nov 07; Vol. 330 (17), pp. 1631-1640.
Autor:
Rosenstock J; From Velocity Clinical Research at Medical City (J.R.) and the Division of Endocrinology, Department of Internal Medicine, and the Peter O'Donnell Jr. School of Public Health, University of Texas Southwestern Medical Center (I.L.) - both in Dallas; Swansea University Medical School, Swansea, United Kingdom (S.C.B.); Novo Nordisk, Søborg, Denmark (A.G., B.L.); Servicio de Endocrinología y Nutrición, Hospital Universitario Quironsalud Madrid, Facultad de Medicina, Universidad Europea, Madrid (E.J.); Novo Nordisk, Tokyo (T.N.); Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Bergamo (R.T.), and the Department of Medicine and Surgery, University of Milano Bicocca, Milan (R.T.) - both in Italy; and the Diabetes Unit, Department of Endocrinology and Metabolism, Hadassah Medical Center (O.M.), and the Faculty of Medicine, Hebrew University of Jerusalem (O.M.) - both in Jerusalem., Bain SC; From Velocity Clinical Research at Medical City (J.R.) and the Division of Endocrinology, Department of Internal Medicine, and the Peter O'Donnell Jr. School of Public Health, University of Texas Southwestern Medical Center (I.L.) - both in Dallas; Swansea University Medical School, Swansea, United Kingdom (S.C.B.); Novo Nordisk, Søborg, Denmark (A.G., B.L.); Servicio de Endocrinología y Nutrición, Hospital Universitario Quironsalud Madrid, Facultad de Medicina, Universidad Europea, Madrid (E.J.); Novo Nordisk, Tokyo (T.N.); Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Bergamo (R.T.), and the Department of Medicine and Surgery, University of Milano Bicocca, Milan (R.T.) - both in Italy; and the Diabetes Unit, Department of Endocrinology and Metabolism, Hadassah Medical Center (O.M.), and the Faculty of Medicine, Hebrew University of Jerusalem (O.M.) - both in Jerusalem., Gowda A; From Velocity Clinical Research at Medical City (J.R.) and the Division of Endocrinology, Department of Internal Medicine, and the Peter O'Donnell Jr. School of Public Health, University of Texas Southwestern Medical Center (I.L.) - both in Dallas; Swansea University Medical School, Swansea, United Kingdom (S.C.B.); Novo Nordisk, Søborg, Denmark (A.G., B.L.); Servicio de Endocrinología y Nutrición, Hospital Universitario Quironsalud Madrid, Facultad de Medicina, Universidad Europea, Madrid (E.J.); Novo Nordisk, Tokyo (T.N.); Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Bergamo (R.T.), and the Department of Medicine and Surgery, University of Milano Bicocca, Milan (R.T.) - both in Italy; and the Diabetes Unit, Department of Endocrinology and Metabolism, Hadassah Medical Center (O.M.), and the Faculty of Medicine, Hebrew University of Jerusalem (O.M.) - both in Jerusalem., Jódar E; From Velocity Clinical Research at Medical City (J.R.) and the Division of Endocrinology, Department of Internal Medicine, and the Peter O'Donnell Jr. School of Public Health, University of Texas Southwestern Medical Center (I.L.) - both in Dallas; Swansea University Medical School, Swansea, United Kingdom (S.C.B.); Novo Nordisk, Søborg, Denmark (A.G., B.L.); Servicio de Endocrinología y Nutrición, Hospital Universitario Quironsalud Madrid, Facultad de Medicina, Universidad Europea, Madrid (E.J.); Novo Nordisk, Tokyo (T.N.); Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Bergamo (R.T.), and the Department of Medicine and Surgery, University of Milano Bicocca, Milan (R.T.) - both in Italy; and the Diabetes Unit, Department of Endocrinology and Metabolism, Hadassah Medical Center (O.M.), and the Faculty of Medicine, Hebrew University of Jerusalem (O.M.) - both in Jerusalem., Liang B; From Velocity Clinical Research at Medical City (J.R.) and the Division of Endocrinology, Department of Internal Medicine, and the Peter O'Donnell Jr. School of Public Health, University of Texas Southwestern Medical Center (I.L.) - both in Dallas; Swansea University Medical School, Swansea, United Kingdom (S.C.B.); Novo Nordisk, Søborg, Denmark (A.G., B.L.); Servicio de Endocrinología y Nutrición, Hospital Universitario Quironsalud Madrid, Facultad de Medicina, Universidad Europea, Madrid (E.J.); Novo Nordisk, Tokyo (T.N.); Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Bergamo (R.T.), and the Department of Medicine and Surgery, University of Milano Bicocca, Milan (R.T.) - both in Italy; and the Diabetes Unit, Department of Endocrinology and Metabolism, Hadassah Medical Center (O.M.), and the Faculty of Medicine, Hebrew University of Jerusalem (O.M.) - both in Jerusalem., Lingvay I; From Velocity Clinical Research at Medical City (J.R.) and the Division of Endocrinology, Department of Internal Medicine, and the Peter O'Donnell Jr. School of Public Health, University of Texas Southwestern Medical Center (I.L.) - both in Dallas; Swansea University Medical School, Swansea, United Kingdom (S.C.B.); Novo Nordisk, Søborg, Denmark (A.G., B.L.); Servicio de Endocrinología y Nutrición, Hospital Universitario Quironsalud Madrid, Facultad de Medicina, Universidad Europea, Madrid (E.J.); Novo Nordisk, Tokyo (T.N.); Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Bergamo (R.T.), and the Department of Medicine and Surgery, University of Milano Bicocca, Milan (R.T.) - both in Italy; and the Diabetes Unit, Department of Endocrinology and Metabolism, Hadassah Medical Center (O.M.), and the Faculty of Medicine, Hebrew University of Jerusalem (O.M.) - both in Jerusalem., Nishida T; From Velocity Clinical Research at Medical City (J.R.) and the Division of Endocrinology, Department of Internal Medicine, and the Peter O'Donnell Jr. School of Public Health, University of Texas Southwestern Medical Center (I.L.) - both in Dallas; Swansea University Medical School, Swansea, United Kingdom (S.C.B.); Novo Nordisk, Søborg, Denmark (A.G., B.L.); Servicio de Endocrinología y Nutrición, Hospital Universitario Quironsalud Madrid, Facultad de Medicina, Universidad Europea, Madrid (E.J.); Novo Nordisk, Tokyo (T.N.); Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Bergamo (R.T.), and the Department of Medicine and Surgery, University of Milano Bicocca, Milan (R.T.) - both in Italy; and the Diabetes Unit, Department of Endocrinology and Metabolism, Hadassah Medical Center (O.M.), and the Faculty of Medicine, Hebrew University of Jerusalem (O.M.) - both in Jerusalem., Trevisan R; From Velocity Clinical Research at Medical City (J.R.) and the Division of Endocrinology, Department of Internal Medicine, and the Peter O'Donnell Jr. School of Public Health, University of Texas Southwestern Medical Center (I.L.) - both in Dallas; Swansea University Medical School, Swansea, United Kingdom (S.C.B.); Novo Nordisk, Søborg, Denmark (A.G., B.L.); Servicio de Endocrinología y Nutrición, Hospital Universitario Quironsalud Madrid, Facultad de Medicina, Universidad Europea, Madrid (E.J.); Novo Nordisk, Tokyo (T.N.); Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Bergamo (R.T.), and the Department of Medicine and Surgery, University of Milano Bicocca, Milan (R.T.) - both in Italy; and the Diabetes Unit, Department of Endocrinology and Metabolism, Hadassah Medical Center (O.M.), and the Faculty of Medicine, Hebrew University of Jerusalem (O.M.) - both in Jerusalem., Mosenzon O; From Velocity Clinical Research at Medical City (J.R.) and the Division of Endocrinology, Department of Internal Medicine, and the Peter O'Donnell Jr. School of Public Health, University of Texas Southwestern Medical Center (I.L.) - both in Dallas; Swansea University Medical School, Swansea, United Kingdom (S.C.B.); Novo Nordisk, Søborg, Denmark (A.G., B.L.); Servicio de Endocrinología y Nutrición, Hospital Universitario Quironsalud Madrid, Facultad de Medicina, Universidad Europea, Madrid (E.J.); Novo Nordisk, Tokyo (T.N.); Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Bergamo (R.T.), and the Department of Medicine and Surgery, University of Milano Bicocca, Milan (R.T.) - both in Italy; and the Diabetes Unit, Department of Endocrinology and Metabolism, Hadassah Medical Center (O.M.), and the Faculty of Medicine, Hebrew University of Jerusalem (O.M.) - both in Jerusalem.
Publikováno v:
The New England journal of medicine [N Engl J Med] 2023 Jul 27; Vol. 389 (4), pp. 297-308. Date of Electronic Publication: 2023 Jun 24.
Autor:
Mathieu C; Clinical and Experimental Endocrinology, Katholieke Universiteit Leuven, Leuven, Leuven, Belgium. Electronic address: chantal.mathieu@uzleuven.be., Ásbjörnsdóttir B; Novo Nordisk A/S, Søborg, Denmark., Bajaj HS; LMC Diabetes and Endocrinology, Brampton, ON, Canada., Lane W; Mountain Diabetes and Endocrine Center, Asheville, NC, USA., Matos ALSA; Novo Nordisk A/S, Søborg, Denmark., Murthy S; Lifecare Hospital and Research Centre, Bangalore, India., Stachlewska K; Novo Nordisk A/S, Søborg, Denmark., Rosenstock J; Velocity Clinical Research at Medical City, Dallas, TX, USA.
Publikováno v:
Lancet (London, England) [Lancet] 2023 Jun 10; Vol. 401 (10392), pp. 1929-1940. Date of Electronic Publication: 2023 May 05.
Autor:
Rosenstock J; From the Dallas Diabetes Research Center at Medical City, Dallas (J.R.); LMC Diabetes and Endocrinology, Brampton (H.S.B.), Leadership Sinai Centre for Diabetes, Mount Sinai Hospital, Toronto (H.S.B.), and LMC Diabetes and Endocrinology, Vaughan (R.G.) - all in Ontario, Canada; the Department of Endocrinology, Diabetes, and Metabolic Diseases, University Medical Center Ljubljana, Ljubljana, Slovenia (A.J.); Southern New Hampshire Diabetes and Endocrinology, Nashua (R.S.); and Novo Nordisk, Søborg, Denmark (K.B., M.V.H., T.J.)., Bajaj HS; From the Dallas Diabetes Research Center at Medical City, Dallas (J.R.); LMC Diabetes and Endocrinology, Brampton (H.S.B.), Leadership Sinai Centre for Diabetes, Mount Sinai Hospital, Toronto (H.S.B.), and LMC Diabetes and Endocrinology, Vaughan (R.G.) - all in Ontario, Canada; the Department of Endocrinology, Diabetes, and Metabolic Diseases, University Medical Center Ljubljana, Ljubljana, Slovenia (A.J.); Southern New Hampshire Diabetes and Endocrinology, Nashua (R.S.); and Novo Nordisk, Søborg, Denmark (K.B., M.V.H., T.J.)., Janež A; From the Dallas Diabetes Research Center at Medical City, Dallas (J.R.); LMC Diabetes and Endocrinology, Brampton (H.S.B.), Leadership Sinai Centre for Diabetes, Mount Sinai Hospital, Toronto (H.S.B.), and LMC Diabetes and Endocrinology, Vaughan (R.G.) - all in Ontario, Canada; the Department of Endocrinology, Diabetes, and Metabolic Diseases, University Medical Center Ljubljana, Ljubljana, Slovenia (A.J.); Southern New Hampshire Diabetes and Endocrinology, Nashua (R.S.); and Novo Nordisk, Søborg, Denmark (K.B., M.V.H., T.J.)., Silver R; From the Dallas Diabetes Research Center at Medical City, Dallas (J.R.); LMC Diabetes and Endocrinology, Brampton (H.S.B.), Leadership Sinai Centre for Diabetes, Mount Sinai Hospital, Toronto (H.S.B.), and LMC Diabetes and Endocrinology, Vaughan (R.G.) - all in Ontario, Canada; the Department of Endocrinology, Diabetes, and Metabolic Diseases, University Medical Center Ljubljana, Ljubljana, Slovenia (A.J.); Southern New Hampshire Diabetes and Endocrinology, Nashua (R.S.); and Novo Nordisk, Søborg, Denmark (K.B., M.V.H., T.J.)., Begtrup K; From the Dallas Diabetes Research Center at Medical City, Dallas (J.R.); LMC Diabetes and Endocrinology, Brampton (H.S.B.), Leadership Sinai Centre for Diabetes, Mount Sinai Hospital, Toronto (H.S.B.), and LMC Diabetes and Endocrinology, Vaughan (R.G.) - all in Ontario, Canada; the Department of Endocrinology, Diabetes, and Metabolic Diseases, University Medical Center Ljubljana, Ljubljana, Slovenia (A.J.); Southern New Hampshire Diabetes and Endocrinology, Nashua (R.S.); and Novo Nordisk, Søborg, Denmark (K.B., M.V.H., T.J.)., Hansen MV; From the Dallas Diabetes Research Center at Medical City, Dallas (J.R.); LMC Diabetes and Endocrinology, Brampton (H.S.B.), Leadership Sinai Centre for Diabetes, Mount Sinai Hospital, Toronto (H.S.B.), and LMC Diabetes and Endocrinology, Vaughan (R.G.) - all in Ontario, Canada; the Department of Endocrinology, Diabetes, and Metabolic Diseases, University Medical Center Ljubljana, Ljubljana, Slovenia (A.J.); Southern New Hampshire Diabetes and Endocrinology, Nashua (R.S.); and Novo Nordisk, Søborg, Denmark (K.B., M.V.H., T.J.)., Jia T; From the Dallas Diabetes Research Center at Medical City, Dallas (J.R.); LMC Diabetes and Endocrinology, Brampton (H.S.B.), Leadership Sinai Centre for Diabetes, Mount Sinai Hospital, Toronto (H.S.B.), and LMC Diabetes and Endocrinology, Vaughan (R.G.) - all in Ontario, Canada; the Department of Endocrinology, Diabetes, and Metabolic Diseases, University Medical Center Ljubljana, Ljubljana, Slovenia (A.J.); Southern New Hampshire Diabetes and Endocrinology, Nashua (R.S.); and Novo Nordisk, Søborg, Denmark (K.B., M.V.H., T.J.)., Goldenberg R; From the Dallas Diabetes Research Center at Medical City, Dallas (J.R.); LMC Diabetes and Endocrinology, Brampton (H.S.B.), Leadership Sinai Centre for Diabetes, Mount Sinai Hospital, Toronto (H.S.B.), and LMC Diabetes and Endocrinology, Vaughan (R.G.) - all in Ontario, Canada; the Department of Endocrinology, Diabetes, and Metabolic Diseases, University Medical Center Ljubljana, Ljubljana, Slovenia (A.J.); Southern New Hampshire Diabetes and Endocrinology, Nashua (R.S.); and Novo Nordisk, Søborg, Denmark (K.B., M.V.H., T.J.).
Publikováno v:
The New England journal of medicine [N Engl J Med] 2020 Nov 26; Vol. 383 (22), pp. 2107-2116. Date of Electronic Publication: 2020 Sep 22.
Autor:
Blonde L; Frank Riddick Diabetes Institute, Department of Endocrinology, Ochsner Medical Center, New Orleans, LA lblonde@ochsner.org., Rosenstock J; Dallas Diabetes Research Center at Medical City, Dallas, TX., Del Prato S; University of Pisa School of Medicine, Pisa, Italy., Henry R; University of California, San Diego, and Center for Metabolic Research, Veterans Affairs San Diego Healthcare System, San Diego, CA., Shehadeh N; Endocrinology, Diabetes, and Metabolism Institute, Rambam Health Care Campus, Haifa, Israel., Frias J; National Research Institute, Los Angeles, CA., Niemoeller E; Sanofi, Frankfurt, Germany., Souhami E; Sanofi, Paris, France., Ji C; Sanofi, Beijing, China., Aroda VR; MedStar Health Research Institute, Hyattsville, MD.; Brigham and Women's Hospital, Boston, MA.
Publikováno v:
Diabetes care [Diabetes Care] 2019 Nov; Vol. 42 (11), pp. 2108-2116. Date of Electronic Publication: 2019 Sep 17.
Autor:
Rosenstock J; Dallas Diabetes Research Center at Medical City, Dallas, Texas., Handelsman Y; Metabolic Institute of America, Tarzana, California., Vidal J; Hospital Clinic of Barcelona, Barcelona, Spain.; Centro Investigación Biomédica en Red en Diabetes y Enfermeades Metabólicas (CIBERDEM), Madrid, Spain., Ampudia Blasco FJ; Clinic University Hospital of Valencia, Valencia, Spain., Giorgino F; University of Bari Aldo Moro, Bari, Italy., Liu M; BDM Consulting, Inc., Somerset, New Jersey., Perfetti R; Sanofi, Bridgewater, New Jersey., Meier JJ; St Josef Hospital, Ruhr-University Bochum, Bochum, Germany.
Publikováno v:
Diabetes, obesity & metabolism [Diabetes Obes Metab] 2018 Dec; Vol. 20 (12), pp. 2821-2829. Date of Electronic Publication: 2018 Aug 13.
Autor:
Roussel R; Inserm U1138, Centre de recherche des Cordeliers, 75006 Paris, France; Université Paris Diderot, Sorbonne Paris Cité, 75013 Paris, France; Département de diabétologie, endocrinologie et nutrition, DHU FIRE, hôpital Bichat, AP-HP, 75018 Paris, France. Electronic address: ronan.roussel@gmail.com., Ritzel R; Division of Endocrinology and Diabetes, Klinikum Schwabing and Klinikum Bogenhausen, Städtisches Klinikum München GmbH, 81925 Munich, Germany., Boëlle-Le Corfec E; Sanofi, 75008 Paris, France., Balkau B; CESP, faculty of medicine, university Paris-South, 94807 Villejuif, France; Faculty of Medicine, University Versailles-St-Quentin, 78000 Versailles, France; Inserm U1018, University Paris-Saclay, 94807 Villejuif, France., Rosenstock J; Dallas Diabetes Research Center at Medical City, Dallas, 75230 TX, USA.
Publikováno v:
Diabetes & metabolism [Diabetes Metab] 2018 Nov; Vol. 44 (5), pp. 402-409. Date of Electronic Publication: 2018 Feb 19.
Autor:
Rosenstock J; Dallas Diabetes Research Center at Medical City, Dallas, TX juliorosenstock@dallasdiabetes.com., Cheng A; Division of Endocrinology and Metabolism, University of Toronto, Toronto, Canada., Ritzel R; Klinikum Schwabing and Klinikum Bogenhausen, Städtisches Klinikum München GmbH, Munich, Germany., Bosnyak Z; Sanofi, Paris, France., Devisme C; AIXIAL, Boulogne-Billancourt, France., Cali AMG; Sanofi, Tokyo, Japan., Sieber J; Sanofi, Frankfurt, Germany., Stella P; Sanofi, Budapest, Hungary., Wang X; Sanofi, Beijing, China., Frías JP; National Research Institute, Los Angeles, CA., Roussel R; Diabetology Endocrinology Nutrition, Hôpital Bichat, DHU FIRE, Assistance Publique Hôpitaux de Paris, Paris, France.; INSERM U-1138, Centre de Recherche des Cordeliers, Paris, France.; UFR de Médecine, Université Paris Diderot, Sorbonne Paris Cité, Paris, France., Bolli GB; Perugia University Medical School, Perugia, Italy.
Publikováno v:
Diabetes care [Diabetes Care] 2018 Oct; Vol. 41 (10), pp. 2147-2154. Date of Electronic Publication: 2018 Aug 13.
Autor:
Home PD; Newcastle University, Newcastle upon Tyne, UK., Lam RLH; Merck & Co., Inc., Kenilworth, New Jersey., Carofano WL; Merck & Co., Inc., Kenilworth, New Jersey., Golm GT; Merck & Co., Inc., Kenilworth, New Jersey., Eldor R; Merck & Co., Inc., Kenilworth, New Jersey., Crutchlow MF; Merck & Co., Inc., Kenilworth, New Jersey., Marcos MC; Merck & Co., Inc., Kenilworth, New Jersey., Rosenstock J; Dallas Diabetes Research Center at Medical City, Dallas, Texas., Hollander PA; Baylor Endocrine Center, Dallas, Texas., Gallwitz B; University of Tübingen, Tübingen, Germany.
Publikováno v:
Diabetes, obesity & metabolism [Diabetes Obes Metab] 2018 Sep; Vol. 20 (9), pp. 2220-2228. Date of Electronic Publication: 2018 Jun 05.